scholarly journals Carotid artery stenting with or without distal filter-type embolic protection device: A single center experience

2021 ◽  
Vol 1 (2-3) ◽  
pp. 41-49
Author(s):  
Ahmet Yabalak ◽  
Murat Yilmaz
Stroke ◽  
2021 ◽  
Vol 52 (Suppl_1) ◽  
Author(s):  
Christine Hawkes ◽  
Aviraj Deshmukh ◽  
Brian van Adel

Introduction: One of the most feared complications of carotid revascularization, including carotid artery stenting (CAS), is peri-procedural ischemic stroke. Several studies suggest that the use of a distal embolic protection device (EPD), as well as over-sized pre- and post-stenting balloon angioplasty, may increase the risk of dislodgement of atheromatous plaque in patients undergoing CAS. The CREST trial, that mandated the use of an EPD, had a peri-procedural ischemic stroke rate of 4.1%. We hypothesize that our technique of stenting without the use of an EPD and sub-maximal angioplasty will have a low risk of peri-procedural complications. Methods: A retrospective review was conducted of consecutive cases of ICA stenting without use of an embolic protection device between January 2012 and June 2020 at a Canadian stroke centre. Data was extracted from the patient electronic medical record and Picture Archives and Communications Systems (PACS). Both symptomatic and asymptomatic CAS cases were included. Results: A total of 220 patients were included in the study, with a median age of 70 years (range 39-93 years), and 83 patients (38%) were female. The vast majority of patients were symptomatic (216 patients [98%]). A large portion of patients had a contralateral ICA occlusion or near occlusion (56 patients [25%]). In the majority of cases, a Precise Cordis RX carotid stent (Cordis) was placed. There were four patients with peri-procedural ischemic strokes (1.8%), with two occurring 8-30 days after stenting. There was one case of acute stent occlusion associated with an ischemic stroke. Two patients (less than 1%) had hyperperfusion syndrome after CAS. Median length of stay following the procedure was one day. Conclusions: In this single centre series, the peri-procedural risks of CAS without using an EPD are low. The ischemic stroke rate is less than 2%, lower than what has been reported in large randomized controlled trials using embolic protection.


2013 ◽  
Vol 83 (6) ◽  
pp. 1014-1020 ◽  
Author(s):  
C. Bauer ◽  
J. Franke ◽  
S.C. Bertog ◽  
V. Woerner ◽  
S. Ghasemzadeh-Asl ◽  
...  

2014 ◽  
Vol 7 (1) ◽  
pp. 130-130
Author(s):  
Luis Henrique de Castro-Afonso ◽  
Lucas Giansante Abud ◽  
Jaicer Gonçalves Rolo ◽  
Antônio Carlos dos Santos ◽  
Lívia de Oliveira ◽  
...  

Acta Medica ◽  
2019 ◽  
Vol 50 (3) ◽  
pp. 44-49
Author(s):  
Ahmet Hakan Ateş ◽  
Aysu Başak Özbalcı ◽  
Selim Kul ◽  
Mustafa Yenerçağ ◽  
Yusuf Ziya Şener ◽  
...  

Objectives The effectiveness of carotid artery stenting (CAS) for primary and secondary prevention of ischemic stroke has been demonstrated in many studies. In this study, we aimed to present the characteristics and post-procedural clinical outcomes of the patients admitted to our clinic with severe carotid artery disease and revascularized by carotid artery stenting (CAS) with distal embolic protection system.   Methods This study was a single- center retrospective study. Between Jan 2015 and May 2017 patients undergoing CAS procedure were included in the study. Symptomatic cases with more than 50% stenosis and asymptomatic patients with more than 70% stenosis were included in the study. Results Twenty-five patients were included in the study. 68% of patients were male with a mean age of 69.3 ± 15.7 years. 92% of patients were symptomatic. In all patients, distal embolic protection devices and self-expandable carotid stents were used. All procedures were performed successfully. No mortality or myocardial infarction was observed in any of the patients in whom CAS was applied successfully. Five complications were seen related to the procedure. One patient had air embolism, one patient had transient ischemic attack, one patient had stroke, one patient had symptomatic nodal rhythm and the last patient had hyper-perfusion syndrome. Conclusion CAS is being successfully applied with acceptable complication rates in experienced centers.


Sign in / Sign up

Export Citation Format

Share Document